Virogen, Inc.'s Technical Consulting Business Model Continues Momentum in Choppy Economy Company's Newest Division Views Future With Optimistic Outlook
SAN GERONIMO, Calif., April 5, 2013 /PRNewswire/ -- Virogen, Inc. (OTCPink: VRNI), a holding company specializing in data security and encryption technology, today announced continuing positive progress of its technical consulting business unit, its new consulting arm. VRNI's new technical consulting unit has identified and successfully recruited highly-skilled technical personnel well-positioned to address any client-defined IT requirements. The company expects to execute ongoing placements throughout the second quarter of this year.
The process of presenting the business unit's IT personnel to its client companies is time consuming, due to the highly sensitive nature of the target positions, especially when the client companies are Fortune 500 firms. However, the current economic environment has caused the IT consulting segment to be one of the few economic segments that appears to be benefiting from the uncertainty surrounding the implementation of the new health care legislation, as there is a growing upward trend in contract recruitment, in general, due to this uncertainty. Thus, this uncertainty serves as the exciting catalyst to VRNI's plans going forward. Because the company has begun to successfully overcome the existing hesitancy of the client-company's operating managers to engage its technical consulting unit, the company remains optimistic about the prospects of its technical consulting unit.
About Virogen, Inc.
Virogen, Inc. is a technology holding company. The company's wholly owned subsidiary, Tiger Team Technologies "T3," has developed a very unique suite of copyrighted tools to address the network and database security needs of enterprise level companies and corporations. T3's risk management offering provides an unprecedented level of security and liability protection, positioning it as the only company with a comprehensive solution to data security breaches for its clients. T3's primary markets include medical service providers, financial services firms, brokerages and currency transaction platforms, consumer credit card companies, banking entities, retailers, defense and government related operations.
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Virogen, Inc. and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions the occurrence of unanticipated events or changes to future operating results.
SOURCE Virogen, Inc.